Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017096221) BISPECIFIC ANTI-HIV BROADLY NEUTRALIZING ANTIBODIES
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2017/096221 International Application No.: PCT/US2016/064713
Publication Date: 08.06.2017 International Filing Date: 02.12.2016
IPC:
A61K 39/395 (2006.01) ,C07K 16/46 (2006.01) ,C12N 15/09 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
395
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
16
Immunoglobulins, e.g. monoclonal or polyclonal antibodies
46
Hybrid immunoglobulins
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
15
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
09
Recombinant DNA-technology
Applicants:
THE ROCKEFELLER UNIVERSITY [US/US]; 1230 York Avenue New York, NY 10065, US
Inventors:
RAVETCH, Jeffrey, V.; US
BOURNAZOUS, Stelios; US
NUSSENZWEIG, Michel; US
Agent:
HAO, Jianming; US
BARRISON, Flynn; US
HALPERN, Nancy, E.; US
BUTCH III, Peter, J.; US
HENRIE, Robert, N.; US
Priority Data:
62/262,09102.12.2015US
Title (EN) BISPECIFIC ANTI-HIV BROADLY NEUTRALIZING ANTIBODIES
(FR) ANTICORPS LARGEMENT NEUTRALISANTS ANTI-VIH BISPÉCIFIQUES
Abstract:
(EN) The present invention relates to bispecific antibodies and, in particular, relates to bispecific anti-HIV broadly neutralizing antibodies and uses thereof.
(FR) La présente invention concerne des anticorps bispécifiques et, en particulier, des anticorps largement neutralisants anti-VIH et leurs utilisations.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)